BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36936209)

  • 1. Assessment of soluble skin surface protein levels for monitoring
    Orro K; Salk K; Abram K; Arshavskaja J; Meikas A; Karelson M; Neuman T; Kingo K; Spee P
    Front Med (Lausanne); 2023; 10():1072160. PubMed ID: 36936209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Invasive Assessment of Skin Surface Proteins of Psoriasis Vulgaris Patients in Response to Biological Therapy.
    Orro K; Salk K; Merkulova A; Abram K; Karelson M; Traks T; Neuman T; Spee P; Kingo K
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in Noninvasive Skin Biomarker Measurements in Daily Practice: A Longitudinal Study on Skin Surface Protein Detection by the Transdermal Analysis Patch in Pediatric Psoriasis.
    Schaap MJ; Bruins FM; van den Brink NJM; Orro K; Groenewoud HMM; de Jong EMGJ; van den Bogaard EH; Seyger MMB
    Skin Pharmacol Physiol; 2022; 35(6):319-327. PubMed ID: 36202075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin Surface Protein Detection by Transdermal Analysis Patches in Pediatric Psoriasis.
    Schaap MJ; Bruins FM; He X; Orro K; Peppelman M; van Erp PEJ; de Jong EMGJ; Koenen HJPM; van den Bogaard EH; Seyger MMB
    Skin Pharmacol Physiol; 2021; 34(5):271-280. PubMed ID: 34015784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of TAP, a non-invasive test for qualitative and quantitative measurements of biomarkers from the skin surface.
    Orro K; Smirnova O; Arshavskaja J; Salk K; Meikas A; Pihelgas S; Rumvolt R; Kingo K; Kazarjan A; Neuman T; Spee P
    Biomark Res; 2014; 2():20. PubMed ID: 25785188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of skin surface biomakers by Transdermal Analyses Patch following different in vivo models of irritation: a pilot study.
    Falcone D; Spee P; Salk K; Peppelman M; van de Kerkhof PCM; van Erp PEJ
    Skin Res Technol; 2017 Aug; 23(3):336-345. PubMed ID: 27800639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser Doppler perfusion imaging (LDPI) and transepidermal water loss (TEWL) values in psoriatic lesions treated with narrow band UVB phototherapy. Dermal vascularity may be useful indicator of psoriatic activity.
    Goh CL; Khoo L
    Ann Acad Med Singap; 2004 Jan; 33(1):75-9. PubMed ID: 15008568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-frequency ultrasonography of psoriatic skin: A non-invasive technique in the evaluation of the entire skin of patients with psoriasis: A pilot study.
    Șomlea MC; Boca AN; Pop AD; Ilieș RF; Vesa SC; Buzoianu AD; Tătaru A
    Exp Ther Med; 2019 Dec; 18(6):4981-4986. PubMed ID: 31798719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome affects narrow-band UVB phototherapy response in patients with psoriasis.
    Rui W; Xiangyu D; Fang X; Long G; Yi Y; Wenjuan W; Tian H; Xiaoning Z; Yong Z; Jianfeng F; Hengjin L; Chengxin L
    Medicine (Baltimore); 2017 Dec; 96(50):e8677. PubMed ID: 29390261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal carotenoid levels in vivo of patients with plaque psoriasis: Effects of narrow-band UVB phototherapy.
    Darlenski R; Deliyska R; Al-Sadek LT; Hristakieva E; Fluhr JW
    Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):111-114. PubMed ID: 33025688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the expression of the stromal cell-derived factor-1 alpha (CXCL 12) in psoriatic patients after treatment with Methotrexate.
    Abdelaal NH; Elhefnawy NG; Abdulmonem SR; Sayed S; Saleh NA; Saleh MA
    J Cosmet Dermatol; 2020 Jan; 19(1):253-258. PubMed ID: 31116013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narrowband-UVB treatment reduces levels of mediators of the Th17 pathway and chemotaxis in psoriatic skin without any concurring effect on mediator levels in serum.
    Duvetorp A; Pettersson K; Söderman J; Assarsson M; Seifert O
    Eur J Dermatol; 2022 Apr; 32(2):250-259. PubMed ID: 35866911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratum corneum levels of calprotectin proteins S100A8/A9 correlate with disease activity in psoriasis patients.
    Matsunaga Y; Hashimoto Y; Ishiko A
    J Dermatol; 2021 Oct; 48(10):1518-1525. PubMed ID: 34165193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The investigation of antimicrobial peptides expression and its related interaction with methotrexate treatment in patients with psoriasis vulgaris.
    Ozlu E; Karadag AS; Ozkanli S; Oguztuzun S; Akbulak O; Uzuncakmak TK; Demirkan S; Akdeniz N
    Cutan Ocul Toxicol; 2017 Dec; 36(4):321-326. PubMed ID: 28067065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
    Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
    J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum YKL-40 in patients with psoriasis vulgaris treated by narrow-band UVB phototherapy.
    Abu El-Hamd M; Adam El Taieb M; Mahmoud AA; Mahmoud Samy O
    J Dermatolog Treat; 2019 Sep; 30(6):545-548. PubMed ID: 30482111
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.
    Jansen PA; Rodijk-Olthuis D; Hollox EJ; Kamsteeg M; Tjabringa GS; de Jongh GJ; van Vlijmen-Willems IM; Bergboer JG; van Rossum MM; de Jong EM; den Heijer M; Evers AW; Bergers M; Armour JA; Zeeuwen PL; Schalkwijk J
    PLoS One; 2009; 4(3):e4725. PubMed ID: 19266104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-125a Correlates with Decreased Psoriasis Severity and Inflammation and Represses Keratinocyte Proliferation.
    Su F; Jin L; Liu W
    Dermatology; 2021; 237(4):568-578. PubMed ID: 33735868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CYR61 in psoriatic lesional and perilesional skin: A clinical and immunohistochemical study.
    Shehata WA; Maraee AH; Abdo EE; Hemida AS
    J Cosmet Dermatol; 2021 Sep; 20(9):2981-2988. PubMed ID: 33484099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.